New Animal Models of Type 2 Diabetes: SDT and SDT Fatty Rat
Two researchers from Japan presented the SDT and SDT fatty rats, two rat models of type 2 diabetes, at an afternoon seminar at PPUKM in Kuala Lumpur.
· Seminar · Co-organised by Prima Nexus
About the seminar
The Department of Pharmacology at Pusat Perubatan Universiti Kebangsaan Malaysia (PPUKM) hosted the seminar in its Level 17 seminar room in Cheras, Kuala Lumpur, on 27 July 2017, from 2.00 pm to 4.00 pm. Prima Nexus co-organised it with Nomura Siam International, a laboratory animal company based in Bangkok, and CLEA Japan. In a letter to the department, Nomura Siam International said the aim was to share knowledge with researchers who work with animal models, especially diabetic rat models.
Two rat models of type 2 diabetes
Two scientists from the Central Pharmaceutical Research Institute of Japan Tobacco Inc. gave the talks. Dr Takeshi Ohta, Special Senior Research Scientist, presented the SDT fatty rat, an obese model of type 2 diabetes. Dr Tomohiko Sasase, Senior Research Scientist, presented the Spontaneously Diabetic Torii (SDT) rat, a non-obese model. Nomura Siam International also introduced its laboratory animal work.
The PPUKM seminar was one stop on a tour by the two speakers. They spoke at Universiti Putra Malaysia (UPM) on the morning of the same day, and at the Laboratory Animal Trade Exhibition 2017 in Bangkok two days earlier.
Prima Nexus's part
Prima Nexus co-organised the seminar with Nomura Siam International and took the registrations. The Prima Nexus logo appears on the seminar poster beside those of Nomura Siam International and CLEA Japan. Today Prima Nexus runs animal studies in rats and mice for Malaysian research groups, including induced models and glucose tolerance tests.




More of our work with UKM.
About Prima Nexus
Prima Nexus Sdn Bhd is a Malaysian research coordination group founded in 2014. It runs hands-on training for researchers across Malaysia and eight scientific platforms under one roof: proteomics (including ELISA and Luminex multiplex immunoassays), genomics, flow cytometry, stem cell research, animal research, clinical trials, bioinformatics, and regulatory and grant support. More about Prima Nexus.